ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1207

A Quality Improvement Intervention to Reduce 30-Day Hospital Readmission Rates Among Patients with Systemic Lupus Erythematosus

Emily Bowers1, Melissa Griffith 1, Elena Weinstein 1, Duane Pearson 1 and Jason Kolfenbach 1, 1University of Colorado Department of Rheumatology, Denver, CO

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: readmission rate and quality improvement, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Measures Of Healthcare Quality Poster II: Improving Care

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic immune-mediated disease with significant morbidity and mortality that often requires inpatient hospitalization. SLE has one of the highest 30-day hospital readmission rates among chronic diseases in the United States with 30-day readmission rates reported in the literature of 16.5-36%. Prior studies have focused on identifying risk factors associated with readmission.  The aim of our study was to reduce 30-day readmission rates among SLE patients at the University of Colorado Hospital by implementing a multidisciplinary post-discharge intervention.

Methods: Using our inpatient consult log, we collected baseline data on the 30-day readmission rate of SLE patients from 7/2016 through 10/2016. We excluded patients who do not get their rheumatology care at our clinic as they would not be impacted by our intervention. We designed a post-discharge intervention that engages the rheumatology fellows, attendings and clinic nurses. We created a message template in the electronic medical record (EMR) that is sent by the rheumatology consult fellow to the clinic nurses when the patient is discharged from the hospital. This includes information about medication changes, future infusions, future labs and follow-up appointments. The nurses contact the patient by telephone within 48 hours of discharge to review the information and answer any questions.  We collected post-intervention data from 12/2018 through 2/2019.

Results: Prior to intervention, 87 patient charts were manually reviewed for inclusion and 18 patients met criteria of having SLE and being followed by our clinic. The 30-day readmission rate among these patients was 44%. The patients who were readmitted within 30 days were 100% female, average age 36 years old, 75% non-Caucasian (Hispanic or African American) and 50% had a public payor form of insurance (Medicare or Medicaid). The reasons for readmission were as follows: 37% SLE flare, 37% infection, 25% other medical issue.  Following our intervention, the 30-day readmission rate among our patients with SLE was 28%, which is a 16% decrease compared to pre-intervention.  Implementation of the intervention was assessed by documentation of the post-discharge message sent by the fellow to the nursing staff in the EMR.  This was found in 28% of hospitalized SLE patients. Of those patients who had the message and intervention performed, only 1 was readmitted within 30 days.

Conclusion: A quality improvement intervention involving a post-discharge telephone call decreased the 30-day readmission rate among patients with SLE followed at the University of Colorado rheumatology clinic from 44% to 28%.  There was overall low implementation of the intervention by the rheumatology fellows, however, this is likely because the intervention was preferentially performed for only the highest risk patients, which was effective in preventing readmission amongst these patients. In the future, we will be working towards more uniform implementation of our intervention. This is one of the first studies to describe a possible intervention to improve the unacceptably high hospital readmission rates among SLE patients.


Disclosure: E. Bowers, None; M. Griffith, None; E. Weinstein, None; D. Pearson, None; J. Kolfenbach, None.

To cite this abstract in AMA style:

Bowers E, Griffith M, Weinstein E, Pearson D, Kolfenbach J. A Quality Improvement Intervention to Reduce 30-Day Hospital Readmission Rates Among Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/a-quality-improvement-intervention-to-reduce-30-day-hospital-readmission-rates-among-patients-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-quality-improvement-intervention-to-reduce-30-day-hospital-readmission-rates-among-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology